SARS-CoV-2 antibody-based SURVEILLANCE: New light in the SHADOW

SARS-CoV-2 antibody-based SURVEILLANCE: New light in the SHADOW

Bibliographic Details
Main Author:	Mario Plebani
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396420304631

Similar Items

Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
by: Giuseppe Lippi, et al.
Published: (2021-05-01)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
by: Yong Xia, et al.
Published: (2020-07-01)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
by: Huibin Lv, et al.
Published: (2020-06-01)

Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
by: Stéphane Le Vu, et al.
Published: (2021-05-01)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
by: Qingqing Lin, et al.
Published: (2020-10-01)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
by: Ren Yang, et al.
Published: (2020-08-01)

SARS-CoV-2 and Anti-Cardiolipin Antibodies
by: Mazen Jizzini, et al.
Published: (2020-12-01)

Genomic surveillance of SARS-CoV-2 in the Republic of Congo
by: Francine Ntoumi, et al.
Published: (2021-04-01)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
by: Hatem A. Elshabrawy
Published: (2020-06-01)

Comprehensive analysis of SARS‐CoV‐2 antibody dynamics in New Zealand
by: Alana L Whitcombe, et al.
Published: (2021-01-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

Comparison between SARS-CoV and SARS-CoV 2
by: Fang Meng
Published: (2021-01-01)

SARS-CoV-2 RNA and antibodies in tear fluid
by: Robert Kuijpers, et al.
Published: (2021-07-01)

The landscape of antibody binding in SARS-CoV-2 infection.
by: Anna S Heffron, et al.
Published: (2021-06-01)

Neutralizing antibody titres in SARS-CoV-2 infections
by: Eric H. Y. Lau, et al.
Published: (2021-01-01)

Antibodies and Vaccines Target RBD of SARS-CoV-2
by: Long Min, et al.
Published: (2021-04-01)

Serological Tests in the Detection of SARS-CoV-2 Antibodies
by: Kissy Guevara-Hoyer, et al.
Published: (2021-04-01)

Breakthroughs in SARS-CoV-2-monoclonal antibodies development
by: Yusuf Muhammed, et al.
Published: (2021-02-01)

Waning antibodies to SARS-CoV-2 – Don't panic
by: Benjamin Meyer
Published: (2021-05-01)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

Global variation in sequencing impedes SARS-CoV-2 surveillance.
by: Dana C Crawford, et al.
Published: (2021-07-01)

SARS-CoV-2 Wastewater Surveillance for Public Health Action
by: Jill S. McClary-Gutierrez, et al.
Published: (2021-09-01)

Wastewater monitoring and public health surveillance of SARS-CoV-2
by: Kumar Manoj
Published: (2020-01-01)

DeepSARS: simultaneous diagnostic detection and genomic surveillance of SARS-CoV-2
by: Agrafiotis, A., et al.
Published: (2022)

Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity
by: Andrea Padoan, et al.
Published: (2020-12-01)

Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies
by: Sally Esmail, et al.
Published: (2021-06-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Improved Detection of Antibodies against SARS-CoV-2 by Microsphere-Based Antibody Assay
by: Carol Ho-Yan Fong, et al.
Published: (2020-09-01)

Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
by: Kening Li, et al.
Published: (2020-11-01)

Clinical performance evaluation of a SARS-CoV-2 Rapid Antibody Test for determining past exposure to SARS-CoV-2
by: Peter Findeisen, et al.
Published: (2021-02-01)

A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody.
by: Nicholas C Wu, et al.
Published: (2020-12-01)

Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera
by: Judith Kannenberg, et al.
Published: (2021-09-01)

Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
by: Maria Skaalum Petersen, et al.
Published: (2020-11-01)

Antibody Responses to SARS-CoV-2 Antigens in Humans and Animals
by: Hyunsuh Kim, et al.
Published: (2020-11-01)

Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia
by: Yuan Liang Woon, et al.
Published: (2021-04-01)

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
by: PJ Klasse, et al.
Published: (2020-06-01)

Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein
by: Antoni G. Wrobel, et al.
Published: (2020-10-01)

Antibody response to SARS-CoV-2 in people living with HIV
by: Shinya Yamamoto, et al.
Published: (2021-02-01)

Neutralizing antibodies targeting SARS-CoV-2 spike protein
by: Shi Xiaojie, et al.
Published: (2021-01-01)